Media releases

Media release: New report highlights system-wide benefits of investing in blood cancer medicines

Media release: Newly funded medicines deliver enhanced care for patients with cancer, multiple sclerosis, and degenerative eye disease

Media release: Statement from Dr Kerryn Symons, Country Medical Director, Roche New Zealand

Media release: Roche welcomes Pharmac's consultation on proposed funding of four treatments for people living with cancer, multiple sclerosis, and eye disease

If approved, these medicines would offer new and more convenient options for people living with cancer, multiple sclerosis (MS), and eye disease

Media release: New market research reveals sight is New Zealand's most valued sense

Nearly nine in 10 New Zealanders would shorten their lives rather than live with vision loss

News release: Exciting news for DLBCL Patients: A New Treatment Option Registered!

Medsafe has registered a new treatment combination: Columvi® (glofitamab) plus chemotherapy (GemOx) in New Zealand

Media release: Ocrevus SC Registration

Media release announcing the registration of Ocrevus SC

Media release : New funding for patients with haemophilia and MS

Patients with haemophilia and multiple sclerosis set to benefit from Roche’s latest multi-medicine agreement with Pharmac

Media release: First ever agreement between Roche and Iwi Māori tribe

First ever agreement between global pharmaceuticals company and Iwi Māori tribal organisation

Media release : New funding for immunotherapy treatment

Roche Products (New Zealand) General Manager Alex Muelhaupt and patient advocate Philip Hope today celebrated new public funding of treatment for lung cancer for patients in New Zealand

Media release: PHARMAC consulting on funding for SMA

PHARMAC consulting on funding for SMA

Media release: Pharmac proposal for lung cancer treatment funding

Multiple new treatments proposed by PHARMAC for lung cancer

Media release : Blood Test for late-stage lung cancer

Blood test may help improve equity for late-stage lung cancer patients